Plunder and Stowaways: Incorporation of Cellular Proteins by Enveloped Viruses

To be successful and have the opportunity to replicate properly, a virus has to thwart or, just the reverse, boost many systems of the host cell. Given that host cells have evolved to eliminate these hostile parasites, a fierce battle ensues. There is now compelling evidence that enveloped virions released from infected cells will carry the vestiges of this battle both internally and externally. The focus of the present minireview will be the incorporation of the host cellular proteins into or onto the newly formed viruses. The roles of a few of these host cellular proteins have been studied, albeit very recently, because of their implication in the biology of some viruses. But for the vast majority, only the observation of their incorporation has been reported in the scientific literature. The various studies in this research area have been conducted with eukaryotic cells infected primarily with RNA enveloped viruses. Human immunodeficiency virus type 1 (HIV-1) has been the most extensively studied in this respect, but other viruses have also contributed to a better understanding of this intriguing phenomenon. A list of the molecules that have been reported to be embedded in some enveloped viruses is shown in Table ​Table1.1. The processes through which cellular proteins are acquired by viruses are still ill defined. Here we will describe and discuss the roles, or potential roles, that the major cellular proteins found associated with enveloped viruses may play in their life cycles. First, the internally associated host cell molecules will be described, and in a second section, the cell surface constituents found included within the envelopes of different viruses will be introduced. TABLE 1. Host cellular molecules acquired by some enveloped viruses

[1]  M. Tremblay,et al.  Interaction between the Cytoplasmic Domain of ICAM-1 and Pr55Gag Leads to Acquisition of Host ICAM-1 by Human Immunodeficiency Virus Type 1 , 2004, Journal of Virology.

[2]  M. Tremblay,et al.  Susceptibility of HIV type 1 to the fusion inhibitor T-20 is reduced on insertion of host intercellular adhesion molecule 1 in the virus membrane. , 2004, The Journal of infectious diseases.

[3]  V. Pathak,et al.  Human Apolipoprotein B mRNA-editing Enzyme-catalytic Polypeptide-like 3G (APOBEC3G) Is Incorporated into HIV-1 Virions through Interactions with Viral and Nonviral RNAs* , 2004, Journal of Biological Chemistry.

[4]  W. Sundquist,et al.  The Human Endosomal Sorting Complex Required for Transport (ESCRT-I) and Its Role in HIV-1 Budding*♦ , 2004, Journal of Biological Chemistry.

[5]  T. Alce,et al.  APOBEC3G Is Incorporated into Virus-like Particles by a Direct Interaction with HIV-1 Gag Nucleocapsid Protein* , 2004, Journal of Biological Chemistry.

[6]  W. Brown,et al.  APOBEC3F Properties and Hypermutation Preferences Indicate Activity against HIV-1 In Vivo , 2004, Current Biology.

[7]  L. Kleiman,et al.  The Interaction between HIV-1 Gag and APOBEC3G* , 2004, Journal of Biological Chemistry.

[8]  M. Malim,et al.  APOBEC-Mediated Editing of Viral RNA , 2004, Science.

[9]  Sunghoon Kim,et al.  Cellular Distribution of Lysyl-tRNA Synthetase and Its Interaction with Gag during Human Immunodeficiency Virus Type 1 Assembly , 2004, Journal of Virology.

[10]  I. Amit,et al.  Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding. , 2004, Genes & development.

[11]  C. Claudel-Renard,et al.  Human Cytomegalovirus Carries a Cell-Derived Phospholipase A2 Required for Infectivity , 2004, Journal of Virology.

[12]  M. Tremblay,et al.  Envelope glycoproteins are not required for insertion of host ICAM-1 into human immunodeficiency virus type 1 and ICAM-1-bearing viruses are still infectious despite a suboptimal level of trimeric envelope proteins. , 2004, Virology.

[13]  B. Cullen,et al.  A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV‐1 and HIV‐2 Vif proteins , 2004, The EMBO journal.

[14]  Takeshi Kurosu,et al.  Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication , 2004, Journal of Virology.

[15]  M. Tremblay,et al.  HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo. , 2004, Clinical immunology.

[16]  H. Garoff,et al.  Passive and Active Inclusion of Host Proteins in Human Immunodeficiency Virus Type 1 Gag Particles during Budding at the Plasma Membrane , 2004, Journal of Virology.

[17]  M. Prevost,et al.  Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding , 2004, Journal of Cell Science.

[18]  S. Isaacs,et al.  Improved protection conferred by vaccination with a recombinant vaccinia virus that incorporates a foreign antigen into the extracellular enveloped virion. , 2004, Virology.

[19]  V. Pathak,et al.  A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  D. Trono,et al.  A Single Amino Acid Determinant Governs the Species-specific Sensitivity of APOBEC3G to Vif Action* , 2004, Journal of Biological Chemistry.

[21]  A. Gatignol,et al.  Identification of Staufen in the Human Immunodeficiency Virus Type 1 Gag Ribonucleoprotein Complex and a Role in Generating Infectious Viral Particles , 2004, Molecular and Cellular Biology.

[22]  N. Landau,et al.  A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Cullen,et al.  A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Booth,et al.  Evidence That HIV Budding in Primary Macrophages Occurs through the Exosome Release Pathway* , 2003, Journal of Biological Chemistry.

[25]  P. De Camilli,et al.  Endophilins interact with Moloney murine leukemia virus Gag and modulate virion production , 2003, Journal of biology.

[26]  M. Tremblay,et al.  Presence of Host ICAM-1 in Human Immunodeficiency Virus Type 1 Virions Increases Productive Infection of CD4+ T Lymphocytes by Favoring Cytosolic Delivery of Viral Material , 2003, Journal of Virology.

[27]  M. Khan,et al.  The Human Immunodeficiency Virus Type 1 Vif Protein Reduces Intracellular Expression and Inhibits Packaging of APOBEC3G (CEM15), a Cellular Inhibitor of Virus Infectivity , 2003, Journal of Virology.

[28]  Jeremy Luban,et al.  Cyclophilin A Interacts with HIV-1 Vpr and Is Required for Its Functional Expression* , 2003, Journal of Biological Chemistry.

[29]  W. Sundquist,et al.  The Protein Network of HIV Budding , 2003, Cell.

[30]  A. Calistri,et al.  AIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding , 2003, Cell.

[31]  H. Zentgraf,et al.  The Mason-Pfizer Monkey Virus PPPY and PSAP Motifs Both Contribute to Virus Release , 2003, Journal of Virology.

[32]  P. Bieniasz,et al.  Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors , 2003, Nature Medicine.

[33]  A. Booth,et al.  The Trojan exosome hypothesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  N. Moussatché,et al.  Redistribution of Cyclophilin A to Viral Factories during Vaccinia Virus Infection and Its Incorporation into Mature Particles , 2003, Journal of Virology.

[35]  Stanislaus S. Wong,et al.  The pH dependence of HIV-1 capsid assembly and its interaction with cyclophilin A. , 2003, Biophysical chemistry.

[36]  L. Arthur,et al.  Cholesterol Depletion of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus with β-Cyclodextrin Inactivates and Permeabilizes the Virions: Evidence for Virion-Associated Lipid Rafts , 2003, Journal of Virology.

[37]  M. Bergeron,et al.  Virion-bound ICAM-1 and activated LFA-1: a combination of factors conferring resistance to neutralization by sera from human immunodeficiency virus type 1-infected individuals independently of the disease status and phase. , 2003, Clinical immunology.

[38]  R. König,et al.  Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif , 2003, Cell.

[39]  S. Scarlata,et al.  Role of HIV-1 Gag domains in viral assembly. , 2003, Biochimica et biophysica acta.

[40]  Gersende Caron,et al.  Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts , 2003, Nature.

[41]  A. Banerjee,et al.  Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype. , 2003, The Journal of general virology.

[42]  M. Malim,et al.  DNA Deamination Mediates Innate Immunity to Retroviral Infection , 2003, Cell.

[43]  D. Gerlier,et al.  Virus Entry, Assembly, Budding, and Membrane Rafts , 2003, Microbiology and Molecular Biology Reviews.

[44]  G. Quérat,et al.  Differential incorporation of uracil DNA glycosylase UNG2 into HIV-1, HIV-2, and SIV(MAC) viral particles. , 2003, Virology.

[45]  Ziying Han,et al.  Overlapping Motifs (PTAP and PPEY) within the Ebola Virus VP40 Protein Function Independently as Late Budding Domains: Involvement of Host Proteins TSG101 and VPS-4 , 2003, Journal of Virology.

[46]  W. Sundquist,et al.  Mechanisms of enveloped RNA virus budding. , 2002, Trends in cell biology.

[47]  D. Ott Potential roles of cellular proteins in HIV‐1 , 2002, Reviews in medical virology.

[48]  Geoffrey L. Smith,et al.  An investigation of incorporation of cellular antigens into vaccinia virus particles. , 2002, The Journal of general virology.

[49]  S. Misumi,et al.  Three Isoforms of Cyclophilin A Associated with Human Immunodeficiency Virus Type 1 Were Found by Proteomics by Using Two-Dimensional Gel Electrophoresis and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry , 2002, Journal of Virology.

[50]  L. M. Mansky,et al.  Roles of uracil-DNA glycosylase and dUTPase in virus replication. , 2002, The Journal of general virology.

[51]  E. Freed,et al.  Viral Late Domains , 2002, Journal of Virology.

[52]  J. Luban,et al.  Specific Incorporation of Heat Shock Protein 70 Family Members into Primate Lentiviral Virions , 2002, Journal of Virology.

[53]  P. Gallay,et al.  Cyclophilin A Plays Distinct Roles in Human Immunodeficiency Virus Type 1 Entry and Postentry Events, as Revealed by Spinoculation , 2002, Journal of Virology.

[54]  D. A. Bosco,et al.  Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  H. Kräusslich,et al.  Differential dependence of the infectivity of HIV-1 group O isolates on the cellular protein cyclophilin A. , 2002, Virology.

[56]  P. Gallay,et al.  trans-Complementation Rescue of Cyclophilin A-Deficient Viruses Reveals that the Requirement for Cyclophilin A in Human Immunodeficiency Virus Type 1 Replication Is Independent of Its Isomerase Activity , 2002, Journal of Virology.

[57]  M. Tremblay,et al.  Presence of Host ICAM-1 in Laboratory and Clinical Strains of Human Immunodeficiency Virus Type 1 Increases Virus Infectivity and CD4+-T-Cell Depletion in Human Lymphoid Tissue, a Major Site of Replication In Vivo , 2002, Journal of Virology.

[58]  E. Freed,et al.  Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. Tremblay,et al.  A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor source. , 2001, The Journal of general virology.

[60]  Wesley I. Sundquist,et al.  Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 Budding , 2001, Cell.

[61]  B. Seed,et al.  Lipid Rafts and Pseudotyping , 2001, Journal of Virology.

[62]  L. Verplank,et al.  Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[63]  M. Bukrinsky,et al.  CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[64]  P. Woodman,et al.  TSG101/Mammalian VPS23 and Mammalian VPS28 Interact Directly and Are Recruited to VPS4-induced Endosomes* , 2001, The Journal of Biological Chemistry.

[65]  W. Song,et al.  Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases. , 2001, International immunopharmacology.

[66]  U. Schubert,et al.  Ubiquitination of HIV-1 and MuLV Gag. , 2000, Virology.

[67]  S. Goff,et al.  The Carboxy-Terminal Fragment of Nucleolin Interacts with the Nucleocapsid Domain of Retroviral Gag Proteins and Inhibits Virion Assembly , 2000, Journal of Virology.

[68]  L. M. Mansky,et al.  The Interaction of Vpr with Uracil DNA Glycosylase Modulates the Human Immunodeficiency Virus Type 1 In Vivo Mutation Rate , 2000, Journal of Virology.

[69]  M. Luo,et al.  The Double-Stranded RNA-Binding Protein Staufen Is Incorporated in Human Immunodeficiency Virus Type 1: Evidence for a Role in Genomic RNA Encapsidation , 2000, Journal of Virology.

[70]  D. Ott,et al.  Efficient Incorporation of HLA Class II onto Human Immunodeficiency Virus Type 1 Requires Envelope Glycoprotein Packaging , 2000, Journal of Virology.

[71]  Dzung H. Nguyen,et al.  Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts , 2000, Journal of Virology.

[72]  M. Bergeron,et al.  Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization. , 2000, Virology.

[73]  Xiao Zhen Zhou,et al.  Actin-binding cellular proteins inside human immunodeficiency virus type 1. , 2000, Virology.

[74]  D. Gerlier,et al.  Measles Virus Structural Components Are Enriched into Lipid Raft Microdomains: a Potential Cellular Location for Virus Assembly , 2000, Journal of Virology.

[75]  P. Gallay,et al.  Host cyclophilin A mediates HIV‐1 attachment to target cells via heparans , 1999, The EMBO journal.

[76]  B. Spire,et al.  Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules. , 1999, AIDS.

[77]  K. Wallengren,et al.  Localization of actin in Moloney murine leukemia virus by immunoelectron microscopy. , 1999, Virology.

[78]  U. Schubert,et al.  Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid. , 1999, Virology.

[79]  H. Kräusslich,et al.  In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A. , 1999, Virology.

[80]  F. Rey,et al.  DNA Repair Enzyme Uracil DNA Glycosylase Is Specifically Incorporated into Human Immunodeficiency Virus Type 1 Viral Particles through a Vpr-Independent Mechanism , 1999, Journal of Virology.

[81]  D. Streblow,et al.  Gag protein from human immunodeficiency virus type 1 assembles in the absence of cyclophilin A. , 1998, Virology.

[82]  J. Paquette,et al.  Level of ICAM-1 Surface Expression on Virus Producer Cells Influences both the Amount of Virion-Bound Host ICAM-1 and Human Immunodeficiency Virus Type 1 Infectivity , 1998, Journal of Virology.

[83]  S. Zolla-Pazner,et al.  Role of cellular adhesion molecules in HIV type 1 infection and their impact on virus neutralization. , 1998, AIDS research and human retroviruses.

[84]  J. Luban,et al.  Human Immunodeficiency Virus Type 1 Replication Is Modulated by Host Cyclophilin A Expression Levels , 1998, Journal of Virology.

[85]  M. Tremblay,et al.  The acquisition of host-encoded proteins by nascent HIV-1. , 1998, Immunology today.

[86]  Robert B Sim,et al.  Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[87]  L. Arthur,et al.  Ubiquitin Is Covalently Attached to the p6GagProteins of Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus and to the p12Gag Protein of Moloney Murine Leukemia Virus , 1998, Journal of Virology.

[88]  Michael M. Endrich,et al.  The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood. , 1998, European journal of biochemistry.

[89]  M. J. Tremblay,et al.  T Cells Expressing Activated LFA-1 Are More Susceptible to Infection with Human Immunodeficiency Virus Type 1 Particles Bearing Host-Encoded ICAM-1 , 1998, Journal of Virology.

[90]  O. Schwartz,et al.  Cytosolic Gag p24 as an Index of Productive Entry of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[91]  M. Bukrinsky,et al.  Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[92]  D. Ott Cellular proteins in HIV virions , 1997, Reviews in medical virology.

[93]  J. Atkinson,et al.  Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. , 1997, The Journal of general virology.

[94]  M. Tremblay,et al.  The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. , 1997, Blood.

[95]  F. Jensen,et al.  Association of ERK2 mitogen-activated protein kinase with human immunodeficiency virus particles , 1997, Journal of virology.

[96]  J. Sodroski,et al.  Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization , 1997, Journal of virology.

[97]  M. Tremblay,et al.  Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity , 1997, Journal of virology.

[98]  J. Luban,et al.  The hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein , 1997, Journal of virology.

[99]  M. Tremblay,et al.  The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity , 1997, Journal of virology.

[100]  L. Arthur,et al.  Cytoskeletal proteins inside human immunodeficiency virus type 1 virions , 1996, Journal of virology.

[101]  J. Luban,et al.  Cyclophilin A is required for the replication of group M human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus SIV(CPZ)GAB but not group O HIV-1 or other primate immunodeficiency viruses , 1996, Journal of virology.

[102]  M. Tremblay,et al.  The amount of host HLA-DR proteins acquired by HIV-1 is virus strain- and cell type-specific. , 1996, Virology.

[103]  L. Picard,et al.  Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A , 1996, Journal of virology.

[104]  P. Cresswell,et al.  HLA class II on HIV particles is functional in superantigen presentation to human T cells: implications for HIV pathogenesis. , 1995, AIDS research and human retroviruses.

[105]  N. Lurain,et al.  Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). , 1995, Journal of immunology.

[106]  L. Young,et al.  Epstein-Barr virus infection of CR2-transfected epithelial cells reveals the presence of MHC class II on the virion. , 1995, Virology.

[107]  S. Zolla-Pazner,et al.  Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 , 1995, The Journal of experimental medicine.

[108]  A. Kurosky,et al.  Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts , 1995, Journal of virology.

[109]  J. Sodroski,et al.  Functional association of cyclophilin A with HIV-1 virions , 1994, Nature.

[110]  J. Luban,et al.  Specific incorporation of cyclophilin A into HIV-1 virions , 1994, Nature.

[111]  R. Luftig,et al.  Viral interactions with the host-cell cytoskeleton: the role of retroviral proteases. , 1994, Trends in microbiology.

[112]  S. Bartz,et al.  An Hsp60 related protein is associated with purified HIV and SIV , 1994, Journal of medical primatology.

[113]  L. Arthur,et al.  Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. , 1992, Science.

[114]  A. Meyerhans,et al.  Selection, recombination, and G----A hypermutation of human immunodeficiency virus type 1 genomes , 1991, Journal of virology.

[115]  V. Vogt,et al.  Ubiquitin in avian leukosis virus particles. , 1990, Virology.

[116]  R. Stein,et al.  Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes. , 1990, Biochemistry.

[117]  P. Griffiths,et al.  Cytomegalovirus strain AD169 binds beta 2 microglobulin in vitro after release from cells. , 1987, The Journal of general virology.

[118]  E. Freed,et al.  Retrovirus budding. , 2004, Virus research.

[119]  H. Kräusslich,et al.  The Human Endosomal Complex Required for Transport I (ESCRT-I) and its Role in HIV-1 Budding* , 2004 .

[120]  M. Esteban,et al.  Recombinant proteins produced by vaccinia virus vectors can be incorporated within the virion (IMV form) into different compartments , 2001, Archives of Virology.

[121]  P. Gallay,et al.  Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells , 2000, Immunologic research.

[122]  C. Seeger,et al.  Hepadnavirus assembly and reverse transcription require a multi‐component chaperone complex which is incorporated into nucleocapsids , 1997, The EMBO journal.

[123]  S. Odend'hal Vesicular Stomatitis Virus (New Jersey Serotype) , 1983 .